These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25295939)

  • 21. Gene therapy: Repair and replace.
    Fischer A
    Nature; 2014 Jun; 510(7504):226-7. PubMed ID: 24870243
    [No Abstract]   [Full Text] [Related]  

  • 22. The γ
    Leonard WJ; Lin JX; O'Shea JJ
    Immunity; 2019 Apr; 50(4):832-850. PubMed ID: 30995502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-cell-replete haploidentical bone marrow transplantation for X-linked severe combined immunodeficiency.
    Ariffin H; Chew KS; Jawin V; Thavagnanam S
    Singapore Med J; 2020 May; 61(5):284-285. PubMed ID: 30128577
    [No Abstract]   [Full Text] [Related]  

  • 24. Applications of TALENs and CRISPR/Cas9 in human cells and their potentials for gene therapy.
    Niu J; Zhang B; Chen H
    Mol Biotechnol; 2014 Aug; 56(8):681-8. PubMed ID: 24870618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developmental progress of CRISPR/Cas9 and its therapeutic applications for HIV-1 infection.
    Deng Q; Chen Z; Shi L; Lin H
    Rev Med Virol; 2018 Sep; 28(5):e1998. PubMed ID: 30024073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNAi as a treatment for HIV-1 infection.
    Rossi JJ
    Biotechniques; 2006 Apr; Suppl():25-9. PubMed ID: 16629384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient ZFN-Mediated Stop Codon Integration into the CCR5 Locus in Hematopoietic Stem Cells: A Possible Source for Intrabone Marrow Cell Transplantation.
    Chattong S; Chaikomon K; Chaiya T; Tangkosakul T; Palavutitotai N; Anusornvongchai T; Manotham K
    AIDS Res Hum Retroviruses; 2018 Jul; 34(7):575-579. PubMed ID: 29575905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Development of TALE Nucleases for Biotechnology.
    Ousterout DG; Gersbach CA
    Methods Mol Biol; 2016; 1338():27-42. PubMed ID: 26443211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biological and biomedical applications of engineered nucleases.
    Pan Y; Xiao L; Li AS; Zhang X; Sirois P; Zhang J; Li K
    Mol Biotechnol; 2013 Sep; 55(1):54-62. PubMed ID: 23089945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene Therapy Approaches to Human Immunodeficiency Virus and Other Infectious Diseases.
    Rogers GL; Cannon PM
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):883-895. PubMed ID: 28895854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 CCR5 gene therapy will fail unless it is combined with a suicide gene.
    Pandit A; de Boer RJ
    Sci Rep; 2015 Dec; 5():18088. PubMed ID: 26674113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Mutations in the IL2RG Gene in 2 Asian Infants With X-linked Severe Combined Immunodeficiency.
    Hara Y; Kobayashi N; Maruyama Y; Motobayashi M; Shigemura T; Ohara O; Agematsu K; Koike K
    J Investig Allergol Clin Immunol; 2015; 25(4):313-5. PubMed ID: 26310054
    [No Abstract]   [Full Text] [Related]  

  • 33. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73: 147-157. 1993.
    Noguchi M; Yi H; Rosenblatt HM; Filipovich AH; Adelstein S; Modi WS; McBride OW; Leonard WJ
    J Immunol; 2008 Nov; 181(9):5817-27. PubMed ID: 18941169
    [No Abstract]   [Full Text] [Related]  

  • 34. A novel model of SCID-X1 reconstitution reveals predisposition to retrovirus-induced lymphoma but no evidence of gammaC gene oncogenicity.
    Scobie L; Hector RD; Grant L; Bell M; Nielsen AA; Meikle S; Philbey A; Thrasher AJ; Cameron ER; Blyth K; Neil JC
    Mol Ther; 2009 Jun; 17(6):1031-8. PubMed ID: 19337236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR genome-editing: A medical revolution.
    Butler JR; Tector AJ
    J Thorac Cardiovasc Surg; 2017 Feb; 153(2):488-491. PubMed ID: 28104200
    [No Abstract]   [Full Text] [Related]  

  • 36. Targeted gene editing enters clinic.
    Ledford H
    Nature; 2011 Mar; 471(7336):16. PubMed ID: 21368795
    [No Abstract]   [Full Text] [Related]  

  • 37. Gene therapy for X-linked severe combined immunodeficiency: Historical outcomes and current status.
    Pai SY; Thrasher AJ
    J Allergy Clin Immunol; 2020 Aug; 146(2):258-261. PubMed ID: 32561390
    [No Abstract]   [Full Text] [Related]  

  • 38. Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.
    Mamcarz E; Zhou S; Lockey T; Abdelsamed H; Cross SJ; Kang G; Ma Z; Condori J; Dowdy J; Triplett B; Li C; Maron G; Aldave Becerra JC; Church JA; Dokmeci E; Love JT; da Matta Ain AC; van der Watt H; Tang X; Janssen W; Ryu BY; De Ravin SS; Weiss MJ; Youngblood B; Long-Boyle JR; Gottschalk S; Meagher MM; Malech HL; Puck JM; Cowan MJ; Sorrentino BP
    N Engl J Med; 2019 Apr; 380(16):1525-1534. PubMed ID: 30995372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ex vivo gene therapy for HIV-1 treatment.
    Scherer LJ; Rossi JJ
    Hum Mol Genet; 2011 Apr; 20(R1):R100-7. PubMed ID: 21505069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.
    Tebas P; Stein D; Tang WW; Frank I; Wang SQ; Lee G; Spratt SK; Surosky RT; Giedlin MA; Nichol G; Holmes MC; Gregory PD; Ando DG; Kalos M; Collman RG; Binder-Scholl G; Plesa G; Hwang WT; Levine BL; June CH
    N Engl J Med; 2014 Mar; 370(10):901-10. PubMed ID: 24597865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.